COMPLAINANT:<\/p>\n
<\/p>\n
The Complainant is a French multinational biotechnology company (notably active in the field of diagnostic solutions) listed on the NYSE Euronext Paris Stock exchange. Its products are mainly used for diagnosing infectious diseases. They are also used for detecting microorganisms in agri-food, pharmaceutical and cosmetic products. It was founded in 1963 and serves more than 160 countries by means of its 43 subsidiaries around the world and through a large network of distributors. Its leadership in the field of in vitro diagnostics lasts for over 60 years, with €4.0 billion in sales. The Complainant or its subsidiaries, is also the owner of many domain names that include the term “biomerieux”, such as <biomerieux.com> which was registered on 31 May 1996 and is used as the address for the Complainant’s website.<\/p>\n
<\/p>\n
The disputed domain name was registered on 6 October 2025 and resolves to a parking page with commercial pay-per-click links.<\/p>\n
<\/p>\n
RESPONDENT:<\/p>\n
<\/p>\n
No administratively compliant Response has been filed.<\/p>", "other_legal_proceedings": "
The Panel is not aware of any other legal proceedings which are pending or decided and which relate to the disputed domain name.<\/p>", "no_response_filed": "
COMPLAINANT:<\/p>\n
<\/p>\n
- the Complainant has rights in the registered BIOMERIEUX trademark and the <merieuxbio.com> domain name is identical or confusingly similar to the trademark;<\/p>\n
<\/p>\n
- the Respondent has no rights or legitimate interests in the disputed domain name as it is not commonly known thereby, and the domain name resolves to a page with pay-per-click links that seek to leverage the reputation of the Complainant’s distinctive trademark; and<\/p>\n
<\/p>\n
- the disputed domain name was registered and is used in bad faith where the Respondent had prior knowledge of the Complainant’s trademark and the domain name’s resolving pay-per-click page seeks commercial gain based on confusion with the trademark.<\/p>\n
<\/p>\n
RESPONDENT:<\/p>\n
<\/p>\n
No administratively compliant Response has been filed.<\/p>", "rights": "
The Complainant has, to the satisfaction of the Panel, shown the disputed domain name is identical or confusingly similar to a trademark or service mark in which the Complainant has rights (within the meaning of paragraph 4(a)(i) of the Policy).<\/p>", "no_rights_or_legitimate_interests": "
The Complainant has, to the satisfaction of the Panel, shown the Respondent to have no rights or legitimate interests in respect of the disputed domain name (within the meaning of paragraph 4(a)(ii) of the Policy).<\/p>", "bad_faith": "
The Complainant has, to the satisfaction of the Panel, shown the disputed domain name has been registered and is being used in bad faith (within the meaning of paragraph 4(a)(iii) of the Policy).<\/p>", "procedural_factors": "
The Panel is satisfied that all procedural requirements under UDRP were met and there is no other reason why it would be inappropriate to provide a decision.<\/p>", "decision": "Accepted", "panelists": [ "Steven Levy Esq. (Presiding Panelist)" ], "date_of_panel_decision": "2025-12-05 00:00:00", "informal_english_translation": "
The Complainant is the owner of the following trademark registrations:<\/p>\n
<\/p>\n
International Trademark BIOMERIEUX n° 933 598, registered on 12 June 2007 (duly renewed since then) in classes 1, 5, 9 and 10, under priority of the French trademark registration n° 06 3 470 357 dated on 1 June 2007. This registration covers Antigua and Barbuda, Bahrain, Bonaire, Saint Eustatius and Saba, Curaçao, European Union, Georgia, Iceland, Japan, Republic of Korea, Norway, Singapore, Sint Maarten (Dutch part), Syria, Turkmenistan, Turkey, Uzbekistan, Zambia, Albania, Armenia, Azerbaijan, Bosnia and Herzegovina, Bhutan, Belarus, Switzerland, China, Cuba, Egypt, Croatia, Islamic Republic of Iran, Kenya, Kyrgyzstan, Democratic People’s Republic of Korea, Kazakhstan, Liechtenstein, Liberia, Lesotho, Morocco, Monaco, Republic of Moldova, Montenegro, The Former Yugoslav Republic of Macedonia, Mongolia, Mozambique, The Republic of Namibia, Serbia, Russian Federation, Sudan, Sierra Leone, San Marino, Swaziland, Tajikistan, Ukraine, Viet Nam, Algeria, Australia, Ghana, Gambia, Botswana, Colombia, Laos, Madagascar, New Zealand, Oman, Rwanda, Zimbabwe;<\/p>\n
<\/p>\n
International Trademark BIOMERIEUX n° 1392389, registered on 25 October 2017 in classes 35, 37, 41, 42 and 44, covering Antigua and Barbuda, Albania, Armenia, Australia, Azerbaijan, Bosnia and Herzegovina, Brunei, Bonaire, Sint Eustatius and Saba, Bhutan, Botswana, Belarus, Switzerland, China, Colombia, Cuba, Curaçao, Algeria, Egypt, Georgia, Ghana, Gambia, Israel, India, Iran, Iceland, Japan, Kenya, Kyrgyzstan, Cambodia, Democratic People's Republic of Korea, Republic of Korea, Kazakhstan, Liechtenstein, Liberia, Lesotho, Morocco, Monaco, Republic of Moldova, Montenegro, Madagascar, The former Yugoslav Republic of Macedonia, Mongolia, Mexico, Mozambique, Namibia, Norway, New Zealand, Oman, Philippines, Serbia, Russian Federation, Rwanda, Sudan, Singapore, Sierra Leone, San Marino, Sao Tome and Principe, Sint Maarten, Syrian Arab Republic, Swaziland, Tajikistan, Turkmenistan, Tunisia, Turkey, Ukraine, United States of America, Uzbekistan, Viet Nam, Zambia, Zimbabwe;<\/p>\n
<\/p>\n
International Trademark n° 1478156, registered on 4 June 2018 in classes 1, 5, 9, 10, 35, 37, 41, 42 and 44, covering Antigua and Barbuda, Albania, Armenia, Australia, Azerbaijan, Bosnia, Bahrain, Brunei, Bonaire, Sint Eustatius and Saba, Bhutan, Botswana, Belarus, Switzerland, China, Colombia, Cuba, Curaçao, Algeria, Egypt, Georgia, Ghana, Gambia, Croatia, Indonesia, Israel, India, Iran, Iceland, Japan, Kenya, Kyrgyzstan, Cambodia, Republic of Korea, Kazakhstan, Lao People’s Democratic Republic, Liechtenstein, Liberia, Lesotho, Morocco, Monaco, Republic of Moldova, Montenegro, Madagascar, North Macedonia, Mongolia, Mexico, Mozambique, Namibia, Norway, New Zealand, Oman, Philippines, Serbia, Russian Federation, Rwanda, Sudan, Singapore, San Marino, Sao Tome and Principe, Sint Maarten, Syrian Arab Republic, Eswatini, Thailand, Tajikistan, Turkmenistan, Tunisia, Turkey, Ukraine, United States of America, Uzbekistan, Vietnam, Zambia, Zimbabwe;<\/p>\n
<\/p>\n
European trademark n° 17912668, registered on 5 June 2018 in classes 1, 5, 9, 10, 35, 37, 41, 42 and 44; and<\/p>\n
<\/p>\n
French trademark n° 4416795, filed on 3 January 2018 in classes 1, 5, 9, 10, 35, 37, 41, 42 and 44.<\/p>", "decision_domains": { "merieuxbio.com": "TRANSFERRED" } }